Immunogenicity of polysaccharide and conjugatequadrivalent meningococcal ACYW-135 vaccines inhealthy adult volunteers – a randomised clinical trialM. RamasamyK. HaworthClutterbuck Eac.J. BowmanT. NickellsSnapeT. JohnG. Blanchard-RohnerA. Pollard
Alternative Names: MCV-4; Menactra; Menactra Infant/Toddler; Menactra Toddler; MenACYW-TT; Meningo ACWY; Meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria… See more Latest Information Update: 06 Apr 2022 Price : €55 * Buy Profile Note: Adis is an information ...
Generic name:meningococcal conjugate vaccine [me-NIN-je-KOK-al-KON-je-gate-vax-EEN] Brand names:Menactra,MenQuadfi, Menveo (Men-ACYW) Dosage forms:intramuscular powder for injection (-), intramuscular solution (-; polysaccharide tetanus toxoid group ACYW) ...
A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States 2020, Vaccine Citation Excerpt : Vaccine seroresponse rates were similar and the overall immunogenicity profile was comparable to findings fr...
These include: (i) unusual transmission pathways of meningococci; (ii) the impact of conjugate vaccines and meningococcal serogroup B (MenB) vaccination on disease and carriage; and (iii) the risk of invasive disease in specific occupations. The surveillance, epidemiology and prevention of IMD in...
one comparator group received 2 doses of the Japanese encephalitis vaccine Ixiaro®. The other comparator group received the quadrivalent meningococcal conjugate vaccine as a first dose and placebo as a 2nd dose. Therefore, safety outcomes observed in recipients of the 2nd 4CMenB dose were compare...
Although direct protection is an important component of meningococcal vaccination strategies, reducing meningococcal carriage and transmission can also be crucial for reducing IMD on a population level. In addition to inducing protective antibodies, meningococcal conjugate vaccines have the ability to reduce ...
MenACYW-TT administered with routine pediatric vaccines was immunogenic and safe in healthy infants and toddlers. DISCLOSURES. James Campbell, GSK: Contracts with my University to perform vaccine clinical trials|Merck: Contracts with my University to perform vaccine clinical trials|Moderna: Contracts ...
P-632. Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlersdoi:10.1093/ofid/ofae631.829BACKGROUND. MenACYW conjugate vaccine (MenACYW-TT) is a quadrivalent meningococcal conjugate vaccine, licensed ...
Stage I of this study (NCT04142242) demonstrated the safety and immunogenicity of a booster dose of a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) and immune persistence 3 and 6-7years after priming in older adults who received either quadrivalent meningococcal ...